MoonLake Immunotherapeutics Class A Ordinary Shares

MLTX

...

MLTX: MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Show MLTX Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of MLTX by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by MLTX's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on MLTX's company Twitter account

WallStreetBets

Number of mentions of MLTX in WallStreetBets Daily Discussion

MLTX News

Recent insights relating to MLTX

CNBC Recommendations

Recent picks made for MLTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MLTX

Corporate Flights

Flights by private jets registered to MLTX